The India POC Immunoassay Analyzers Market value was US$ $$ billion in 2022. The India POC Immunoassay Analyzers Market value is forecast to reach US$ $$ billion by 2032, growing at a compound annual ...

BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals COPENHAGEN, DENMARK, January 23, 2025 (GLOBE NEWSWIRE) – BioPorto, an in vitro ...

Shares of CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report) crossed above its two hundred day moving average during ...

Medix said the acquisition adds to its portfolio of raw materials used for in vitro diagnostics development and improves its ability to support immunoassay developers.

Immunoassay Kits & Reagents Dominate: These kits hold the largest market share (67.8% in 2022) and are predicted to grow ...

The procalcitonin (PCT) assay market industry in the United States is predicted to reach USD 202.0 million by 2033, ...

Sapient will be an Alamar certified service provider for Alamar's NULISAseq Inflammation panel and its NULISAseq CNS Disease panel.

NULISA employs a sequential immunocomplex capture and release technique to improve the sensitivity of traditional proximity ...

Beckman Coulter Diagnostics, a global leader in advanced diagnostics, today announced availability of new Research Use Only ...

Revvity, Inc. RVTY announced the receipt of the FDA’s 510(k) clearance for EUROIMMUN’s automated chemiluminescence-based ...

The US Food and Drug Administration (FDA) has cleared Revvity’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone. The authorisation by the agency marks the first time a ...